Illmer T - Search Results

1

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Thiede C, Steudel C, Mohr B, Schaich M, Schäkel U, Platzbecker U, Wermke M, Bornhäuser M, Ritter M, Neubauer A, Ehninger G, Illmer T. Thiede C, et al. Among authors: illmer t. Blood. 2002 Jun 15;99(12):4326-35. doi: 10.1182/blood.v99.12.4326. Blood. 2002. PMID: 12036858 Free article.

2

Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.

Schaich M, Harbich-Brutscher E, Pascheberg U, Mohr B, Soucek S, Ehninger G, Illmer T. Schaich M, et al. Among authors: illmer t. Haematologica. 2002 May;87(5):455-64. Haematologica. 2002. PMID: 12010657

3

Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia.

Schaich M, Illmer T. Schaich M, et al. Among authors: illmer t. Leuk Lymphoma. 2002 Jul;43(7):1345-54. doi: 10.1080/10428190290033279. Leuk Lymphoma. 2002. PMID: 12389613 Review.

4

Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.

Steudel C, Wermke M, Schaich M, Schäkel U, Illmer T, Ehninger G, Thiede C. Steudel C, et al. Among authors: illmer t. Genes Chromosomes Cancer. 2003 Jul;37(3):237-51. doi: 10.1002/gcc.10219. Genes Chromosomes Cancer. 2003. PMID: 12759922

5

Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts.

Illmer T, Thiede C, Fredersdorf A, Stadler S, Neubauer A, Ehninger G, Schaich M. Illmer T, et al. Clin Cancer Res. 2005 May 1;11(9):3217-24. doi: 10.1158/1078-0432.CCR-04-2232. Clin Cancer Res. 2005. PMID: 15867216

6

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M, Ehninger G. Thiede C, et al. Among authors: illmer t. Blood. 2006 May 15;107(10):4011-20. doi: 10.1182/blood-2005-08-3167. Epub 2006 Feb 2. Blood. 2006. PMID: 16455956 Free article.

7

FLT3 kinase inhibitors in the management of acute myeloid leukemia.

Illmer T, Ehninger G. Illmer T, et al. Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 1:S24-34. doi: 10.3816/clm.2007.s.030. Clin Lymphoma Myeloma. 2007. PMID: 18282363 Review.

8

The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.

Schaich M, Illmer T, Seitz G, Mohr B, Schäkel U, Beck JF, Ehninger G. Schaich M, et al. Among authors: illmer t. Haematologica. 2001 May;86(5):470-7. Haematologica. 2001. PMID: 11410409 Clinical Trial.

9

The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia.

Seifert H, Mohr B, Thiede C, Oelschlägel U, Schäkel U, Illmer T, Soucek S, Ehninger G, Schaich M; Study Alliance Leukemia (SAL). Seifert H, et al. Among authors: illmer t. Leukemia. 2009 Apr;23(4):656-63. doi: 10.1038/leu.2008.375. Epub 2009 Jan 8. Leukemia. 2009. PMID: 19151774

10

Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.

Schaich M, Illmer T, Aulitzky W, Bodenstein H, Clemens M, Neubauer A, Repp R, Schäkel U, Soucek S, Wandt H, Ehninger G; SHG AML96 Study Group. Schaich M, et al. Among authors: illmer t. Haematologica. 2002 Aug;87(8):808-15. Haematologica. 2002. PMID: 12161356 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters